When is treatment recommended by the NIH for chronic hepatitis B (HBV) (Hep B)?

Updated: Aug 01, 2018
  • Author: Nikolaos T Pyrsopoulos, MD, PhD, MBA, FACP, AGAF; Chief Editor: BS Anand, MD  more...
  • Print
Answer

In general, for hepatitis B e antigen (HBeAg)-positive patients with evidence of chronic HBV disease, treatment is advised when the HBV DNA level is at or above 20,000 IU/mL (105 copies/mL) (or, per the EASL, >2,000 IU/mL [56] ) and when serum ALT is elevated for 3-6 months. [2, 37, 54]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!